Přehled studií citovaných v článcích tohoto čísla Kardiologické revue

Česká verzia

Vyšlo v časopise: Kardiol Rev Int Med 2006, 8(3): 147

ASCOT-LLA – Anglo-Scandinavian Cardiac Outcomes Trial-lipid-lowering arm
ASPEN – Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent Diabetes Mellitus
BARI II – Bypass Angioplasty Revascularization Investigation II
BETACAR – Betaxolol versus Carvedilol in Chronic Heart Failure
BIPS – Bezafibrat Infarction Prevention Study
CAPRICORN – Carvedilol Post Infarct Survival Control in LVD
CAPRIE – Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE) study
CARDS – Collaborative Atorvastatin Diabetes Study
CARE – Cholesterol And Recurrent Events
CIBIS II – The Second Cardiac Insufficiency Bisoprolol Study
CLARITY – Cladribine Tablets in Treating MS Orally Study
COMET – Carvedilol or Metoprolol European Trial Study
COMMIT/CCS-2 – Clopidogrel and Metoprolol in Myocardial Infarction Trial Study
COPERNICUS – Carvedilol Prospective Randomized Cumulative Survival
CREDO – The Clopidogrel for the Reduction of Events During Observation Study
CURE – The Clopidogrel in Unstable Angina to Prevent Recurrent Events
DAIS – Diabetes Atherosclerosis Intervention Study
DCCT – Diabetes Control and Complications Trial Study
DIGAMI – Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction
DIGAMI II – Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction 2
EDIC – Epidemiology of Diabetes Interventions and Complications Study
ETDRS – Early Treatment Diabetic Retinopathy Study
EUROPA – European Trial on Reduction of Cardiac Events with Perindopril in Stable Artery Coronary Disease
FIELD – Fenofibrate Intervention and Event Lowering in Diabetes
GREACE – Greek Atorvastatin and Coronary-heart-disease Evaluation
HOPE – Heart Outcomes Prevention Study
HPS – Heart Protection Study
CHARISMA – Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance
ISAR – Diabetes Study Paclitaxel-eluting and Sirolimus-eluting stents to Prevent Restenosis in Diabetic Patients
ISIS-1 – Second International Study of Infarct Survival
LATE-BASKET – Late Clinical Events Related to Late Stent Thrombosis After Stopping Clopidogrel: Drug-Eluting vs Bare-Metal Stenting
LIPID – Long-term Intervention with Pravastatin in Ischemic Disease
MADIT II – Multicenter Automatic Defibrillator Implantation Trial II
MERIT HF – The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure Study
MIAMI – Metoprolol in Acute Myocardial Infarction Study
MIRACLE – Multicenter InSync Randomized Clinical Evaluation
ONTARGET – Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial Study
PEACE – Prevention of Events with Angiotensin-Converting Enzyme Inhibition
PHS – Physicians’ Health Study
POPADAD – The Prevention of Progression of Asymptomatic Diabetic Arterial Disease Study
PPP – Primary Prevention Project
PROACTIVE – Prospective Pioglitazone Clinical Trial in Macro Vascular Events
SCORE – The Standard Care vs. Corticosteroid for Retinal Vein Occlusion Study
SENIORS – Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure
SIRIUS – SirolimUS-Eluting Stent in De Novo Native Coronary Lesions
STOP NIDDM – Study to Prevent Non-Insulin-Dependent Diabetes Mellitus
TIMI-2B – Thrombolysis in Myocardial Infarction 2B Study
TNT – The Treating to New Targets
UKPDS – United Kingdom Prospective Diabetes Study
4S – Scandinavian Simvastatin Survival Study.